Home > Publications database > Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. > print

001     298904
005     20250427020206.0
024 7 _ |a 10.1038/s41431-025-01786-0
|2 doi
024 7 _ |a pmid:39939714
|2 pmid
024 7 _ |a 1018-4813
|2 ISSN
024 7 _ |a 1476-5438
|2 ISSN
024 7 _ |a altmetric:174211020
|2 altmetric
037 _ _ |a DKFZ-2025-00343
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dicks, Ed M
|0 0000-0002-0617-0401
|b 0
245 _ _ |a Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.
260 _ _ |a Basingstoke
|c 2025
|b Stockton Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1745566487_21578
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 33, pages 297–303 (2025)
520 _ _ |a Rare, germline loss-of-function variants in a handful of DNA repair genes are associated with epithelial ovarian cancer. The aim of this study was to evaluate the role of rare, coding, loss-of-function variants across the genome in epithelial ovarian cancer. We carried out a gene-by-gene burden test with various histotypes using data from 2573 non-mucinous cases and 13,923 controls. Twelve genes were associated at a False Discovery Rate of less than 0.1 of which seven were the known ovarian cancer susceptibility genes BRCA1, BRCA2, BRIP1, RAD51C, RAD51D, MSH6 and PALB2. The other five genes were OR2T35, HELB, MYO1A and GABRP which were associated with non-high-grade serous ovarian cancer and MIGA1 which was associated with high-grade serous ovarian cancer. Further support for the association of HELB association comes from the observation that loss-of-function variants in HELB are associated with age at natural menopause and Mendelian randomisation analysis shows an association between genetically predicted age at natural menopause and endometrioid ovarian cancer, but not high-grade serous ovarian cancer.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Tyrer, Jonthan P
|0 0000-0003-3724-4757
|b 1
700 1 _ |a Ezquina, Suzana
|b 2
700 1 _ |a Jones, Michelle
|b 3
700 1 _ |a Baierl, John
|b 4
700 1 _ |a Peng, Pei-Chen
|b 5
700 1 _ |a Diaz, Michael
|b 6
700 1 _ |a Goode, Ellen
|b 7
700 1 _ |a Winham, Stacey J
|b 8
700 1 _ |a Dörk, Thilo
|b 9
700 1 _ |a Gorp, Toon Van
|b 10
700 1 _ |a Fazio, Anna De
|b 11
700 1 _ |a Bowtell, David D L
|b 12
700 1 _ |a Garsed, Dale W
|b 13
700 1 _ |a Odunsi, Kunle
|b 14
700 1 _ |a Moysich, Kirsten
|b 15
700 1 _ |a Pavanello, Marina
|b 16
700 1 _ |a Fostira, Florentia
|b 17
700 1 _ |a Webb, Penelope M
|b 18
700 1 _ |a Soukupová, Jana
|b 19
700 1 _ |a Cohen, Paul A
|b 20
700 1 _ |a Sieh, Weiva
|b 21
700 1 _ |a Fortner, Renée Turzanski
|0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
|b 22
|u dkfz
700 1 _ |a Ricker, Charite
|b 23
700 1 _ |a Karlan, Beth
|b 24
700 1 _ |a Campbell, Ian
|b 25
700 1 _ |a Brenton, James D
|b 26
700 1 _ |a Ramus, Susan J
|b 27
700 1 _ |a Gayther, Simon A
|b 28
700 1 _ |a Pharoah, Paul D P
|0 0000-0001-8494-732X
|b 29
773 _ _ |a 10.1038/s41431-025-01786-0
|0 PERI:(DE-600)2005160-8
|p 297–303
|t European journal of human genetics
|v 33
|y 2025
|x 1018-4813
909 C O |p VDB
|o oai:inrepo02.dkfz.de:298904
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-27
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J HUM GENET : 2022
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J HUM GENET : 2022
|d 2024-12-27
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21